It functions by inducing cell cycle arrest in ovarian cancer cells, specifically halting growth at the G0/G1 phase, which is achieved through the suppression of cyclin E, a protein crucial for cell cycle progression. This evidence concerns the gene CCNE1 and ovarian carcinoma.